Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Harvard Business School
Merck
Express Scripts
Moodys

Last Updated: August 17, 2022

Investigational Drug Information for Filgotinib


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Filgotinib?

Filgotinib is an investigational drug.

There have been 32 clinical trials for Filgotinib. The most recent clinical trial was a Phase 3 trial, which was initiated on May 12th 2021.

The most common disease conditions in clinical trials are Arthritis, Arthritis, Rheumatoid, and Colitis, Ulcerative. The leading clinical trial sponsors are Galapagos NV, Gilead Sciences, and Ono Pharmaceutical Co. Ltd.

There are two hundred and twenty-eight US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Filgotinib
TitleSponsorPhase
A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in RemissionGalapagos NVPhase 3
Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic EventsFundación de Investigación Biomédica - Hospital Universitario de La PrincesaPhase 4
Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)Galapagos NVPhase 4

See all Filgotinib clinical trials

Clinical Trial Summary for Filgotinib

Top disease conditions for Filgotinib
Top clinical trial sponsors for Filgotinib

See all Filgotinib clinical trials

US Patents for Filgotinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Filgotinib See Plans and Pricing Methods for the treatment of HER2 amplified cancer Pharmacyclics LLC (Sunnyvale, CA) See Plans and Pricing
Filgotinib See Plans and Pricing Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-.alpha.]pyrrolo[2,3-e]-pyrazin-8-yl)-N-- (2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereof AbbVie Inc. (North Chicago, unknown) See Plans and Pricing
Filgotinib See Plans and Pricing Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA) See Plans and Pricing
Filgotinib See Plans and Pricing Compounds CHIESI FARMACEUTICI S.P.A. (Parma, IT) See Plans and Pricing
Filgotinib See Plans and Pricing Cot modulators and methods of use thereof GILEAD SCIENCES, INC. (Foster City, CA) See Plans and Pricing
Filgotinib See Plans and Pricing Anti-PD-L1 antibodies and uses thereof I-MAB (Grand Cayman, KY) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Filgotinib

Drugname Country Document Number Estimated Expiration Related US Patent
Filgotinib Canada CA2920534 2033-08-12 See Plans and Pricing
Filgotinib European Patent Office EP3033079 2033-08-12 See Plans and Pricing
Filgotinib Spain ES2709509 2033-08-12 See Plans and Pricing
Filgotinib Japan JP2016528251 2033-08-12 See Plans and Pricing
Filgotinib Japan JP2019031546 2033-08-12 See Plans and Pricing
Filgotinib Japan JP2021008475 2033-08-12 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Harvard Business School
Merck
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.